Medicine dissertation Asthma is defined by the National Institute of Health as a chronic respiratory disease of the airways, that is characterized by airway inflammation and hyper-responsiveness, whi

Medicine dissertation Asthma is defined by the National Institute of Health as a chronic respiratory disease of the airways, that is characterized by airway inflammation and hyper-responsiveness, whi

$0.69

$150 $24 & (*truncation) (1), (1.7 (10%, (10), (11), (135), (18.6% (18.9% (1956) (1983) (1986) (1988) (1992) (1994) (1994). (1995) (1995). (1996) (1998-2018), (1999) (1999), (1999). (2 (2), (2.3 (2.9 (20.0% (2000) (2000), (2002) (2002), (2003) (2003–2012). (2004) (2005) (2005), (2006) (2006). (2007) (2008) (2009) (2009), (2009). (2010) (2011) (2012) (2013) (2013). (2014) (2014), (2014). (2015) (2015). (2016) (2016). (2017) (2017). (2018) (2018), (2018). (3), (30 (31%), (36 (4), (46.7%, (5), (5.5 (52 (55.9% (6), (6947), (7), (70 (7203), (76.7%) (78 (8), (9), (<5% (>80%) (Ahmed (Alangari, (Andrade, (Asthma (Becker (Bettany-Saltikov, (Booth (Bousquet (Bowling, (Briel (British (Butland (Camargo (Cowell, (D'Amato (Devidayal (Dumas-Mallet (Farrugia (Fuhlbrigge (GDP; (Garg, (Global (Goertz (Gough (Grewal (Grove (Gupta, (Holgate (Horvath (Jackson (Jayaram (Kang (Karanicolas (Kendall, (Levy (Levy, (Liberati (Lin (Lipstein (Littenberg (Long, (Maselli (Mhaskar (Mims, (Mukherjee (NRAD) (Nici (Nunan (Nunes (Papiris (Pirracchio (Poetker (Qiu (RCT) (RR (RR) (Ramsahai (Ray (Reddel (Resnik, (Roberts (Rodrigo, (STOPIT-2). (Sadatsafavi (Scarfone (Scells (Schneider (Schuh (Suresh, (Torjesen, (Tsafnat (Wenzel, (Yunginger (allergic), (baseline (budesonide) (columns (fluticasone) (high (inhaled (intermediate) (log (low (mean (p<0.001), (p<0.001). (p<0.005). (p<0.01) (p<0.01). (p<0.05). (p=0.001). (p=0.002 (p=0.002). (p=0.005) (p=0.01). (p=0.029). (p=0.03) (p=0.04), (p=0.05). (p=0.118). (p=0.14). (p=0.2). (p=0.33). (p=0.39 (p=0.39). (p=0.47) (p=0.47). (p=0.52), (p=0.52). (p=0.7). (p=0.86 (p=0.95). (peak (population, (prednisolone) (relative (salmeterol) (table (years) *↑; - -0.1). -0.38, -3.3; -5.6, 0.0003). 0.004). 0.03; 0.05 0.13, 0.2, 0.25, 0.35; 0.38; 0.44), 0.47; 0.6% 0.74), 0.89). 0.95), 01/09/2018]. 02/05/2018]. 02/06/2018]. 02/07/2018]. 02/09/2018]. 03/07/2018]. 03/10/2018]. 04/04/2018]. 05/08/2018]. 05/10/2018]. 06/04/2018]. 06/06/2018]. 06/10/2018]. 08/06/2018]. 08/08/2018]. 1 1% 1) 1, 1,000 1-11. 1-12. 1-22. 1-28. 1-3. 1-6. 1-7. 1-Patient* 1. 1.1 1.2 1.3 1.4 1.5 1.6 10 10% 10-Morbidity 10-fold 100,000 101-107. 103 1087-1092. 109-112. 11 11-Mortality 11.1% 112-119. 113-118. 118 12/08/2018]. 120 120, 1208-1213. 122 123 1231-1236. 129 13 13/05/2018]. 130-140. 1320-1323. 139-145. 14 14-24. 145 146 15 15/09/2018]. 150 150-152. 151 154-159. 164-168. 171 172-187. 18-21. 18-50 18-55 180 182-199. 185-185. 187-192. 189-193. 1956) 1958 1964-1983. 1986). 1988, 1988; 1992). 1995), 1999) 1999). 1999; 1st 2 2) 2, 2,547 2,579 2,695 2-12 2-18 2-6. 2-Asthma 2. 2.1 2.2 2.3 2.4 2.5 2.7 20 200 2000) 2000), 2000). 2000; 2002) 2002), 2002). 2002; 2003). 2003; 2004). 2005) 2005), 2005). 2005; 2006). 2006; 2007; 2008). 2009). 2009; 2010). 2011). 2012). 2013). 2014). 2014; 2015). 2016). 2016; 2017). 2018 2018). 2019). 205-216. 209 21-22. 215-221. 23 23/04/2018]. 23/05/2018]. 24 240 244 25 25% 25/08/2018]. 26 26/06/2018]. 26/07/2018]. 27 27/07/2018]. 271 275-284. 278-281. 28 28/08/2018]. 29-32. 3 3, 3-Acute 3. 3.1 3.2 3.3 3.3. 3.4 3.4.1 3.4.2 3.4.3 3.4.4 30 30-39. 30-44. 30.5% 30/05/2018]. 30/08/2018]. 30/09/2018]. 300 3000, 308 314 319 32 33 337-343. 34,000 34-48. 343 344 345-348. 348 37-41. 374 394-395. 4 4, 4-Exacerbation 4. 4.1 4.2 4.2.1 4.2.2 4.3 40%, 40-69% 42 427-438. 43 44 46.4% 48 480-486. 483-494. 487-494. 49-51. 49-56. 5 5-10% 5-17 5-Systemic 5. 50-79% 51 51.4%), 53 548-554. 55 586-590. 6 6, 6-Corticosteroid* 6. 60 60-66. 635-639. 64-68. 64-69. 640-645. 644-650. 647-656. 65-94. 650-658. 66 689-694. 7 7, 7-Steroid* 7. 7.6%, 7.7% 74 753-768. 755-761. 76 787-793. 7th 8 8-11. 8-Outcome* 80% 803-806. 83 835-840. 845-851. 88 888-894. 9 9-Symptom* 9.0%, 9.4%, 90, 95% 977-991. 98 <18 <40% >18 >48 >70% >95%, A A. A., A: AND Abu Accessory Acquah, Acta Acute Addressed Adhikari, Adults Advances Advisory Aftab, After Age Ahmed, Aim Aims Airway Akl, Alangari, All Allergy Allergy, Alonso-Coello, Alothman, Alshehri, Although, Altman, Am Am, An Anaesth, And Andrade, Andrews, Ann Annals Antonicelli, Appendices Applicability Applied Appraisal Appraisal, Approaches Appropriate Apter, Arch Are Aronson, Arora, Arseneault, Article As Aside Assessment Asthma Asthma, Asthma-related Asthma. Asthma: Athletic Authors Automated Available Azzopardi, B. B., BMC BMJ BMJ, Bakalchuk, Bandyopadhyay, Bankhead, Barnes, Baseline Bassler, Becker Becker, Bettany-Saltikov, Bhandari, Bias Blaisdell, Blinding: Bonsignore Bonsignore, Bontly, Boolean Booth, Boraud, Borok, Bota, Both Boulet, Boushey, Bousquet, Bower, Bowling, Breathe, Bretzlaff, Briel, British Britton, Bucher, Buckingham, Bull Burns, Butland, Button, C. C., CASP CASP. CI CINAHL CONTROLLED Calabrese, Camargo, Canada Canadian Canny, Care Care, Cartier, Catalogue Cell Checklists Chen, Chest, Chevret, Chiappara, Children Chrispim, Chronic Clarifying Clarke, Clin Clinical Coates, Cochrane Code Coiera, Collaborators Collaborators, Combinations Comparable Comparator Compare Comparison Concepts Concern Conclusion Conduct Considerations Continuous Cook, Corey, Corticosteroid Corticosteroids Coto-Yglesias, Coulter Coulter, Council Cowell, Creativity Crit Criteria Critical Culebro, Current Curry, D'Amato, D. D., Daines, Database Daures, Davies, Davis, Dayrit, Deacon, Deaths Decker, Delivering Department Design Designing Despite Details Determine Determining Development Devereaux, Devidayal Devidayal, Dhawan, Dibben, Dick, Did Diner, Dis, Discharge Discussion Disease Diseases, Diseases. Dixon, Djulbegovic, Do Dow, Ducharme, Due Dumas Dumas, Dumas-Mallet, Dupuis, E. E., EMBASE, Early Edmonds, Efficacy Elamin, Eligibility Elnour, Elsevier. Emerg Emergency Emerging Emmanuel, Empirical Engl English Epidemiology Epiphaniou, Erwin, Estonian Ethical Ethics Eur Europe European Evaluate Evaluations. Evans, Evidence-Based Evidence. Exacerbation Exacerbations Example Exclusion Exp F. F., Fahy, Fanta Fanta, Farr, Farrokhyar, Farrugia, Ferreira-Gonzalez, Figure Finally, Firstly, Fischbacher, FitzGerald, Fitzsimmons, Flunisolide Flynn, Fontana-Penn, For Forced Forum Fourthly, Framing Francis, From Fuhlbrigge, Furthermore, Future G. G., GDP GDP) GDP), Gagliardo, Garg, Generation Generic Gern, Geva, Gibson, Given Gjomarkaj, Glasziou, Global Gluck, Glucocorticoids Godard, Goertz, Goldsmith, Gonon, Gotzsche, Gough, Gracely, Gray, Grewal, Griffiths, Gross, Grove, Gupta, Guyatt, Gwadry-Sridhar, H. H., Harcup, Hargreave, Hartert, Hartley, Health Health: Heaven, Heels-Ansdell, Henretig, Heyl, Heymann, High High-dose Holgate, Horvath, Hospital Houston, How However, Hum Hussack, I. I., Identify Immunol, Importance Important? Importantly, In Incidence Inclusion Indeed, India Indian Information, Inhaled Initiative Initiatives Institute Int Integrating Integrity Intensive Intention-to-treat Interim Intern Intervention Interventions Investigate Investigating Ioannidis, Issues It J J, J. J., J.-H. Jackson, Jayaram, Jayshree, Joffe, Journal Journal, Journois, Jr. Jr., K. K., Kang, Karanicolas, Karystianis, Kataria, Kauffmann, Kaur, Kendall, Khaikin, Kirpalani, Kleijnen, Kohli, Koopman, Kotanidou, Krishnan Krishnan, Kuhlthau, Kumar, Kunz, L. L., Lampropulos, Lancet, Lane, Language Lanza, Laurent, Laviolette, Le Lee-Wong Lee-Wong, Lemiere, Length Levy Levy, Liberati, Limitations Lin Lin, Lipstein, Literature Littenberg, Loiselle, London, Long, Louis, Low Lowe, Lower Lung Lutz, Lynd, Lyons, M. M., MI, MJA, MRC Mahoney, Malaga, Malagari, Malatack, Management Martinez, Maselli, Maslen, Mauger, Maurizio Mayo, McFadden, McKinstry, Mean Measures Med, Medical Medicine Medicine, Meline, Melton, Methodologies Methodology Methods Metspalu, Mhaskar, Milani, Mills, Mims, Mishra, Moderate Moher, Mol Molino, Montori, Morais-Almeida, Morbidity Moreover, Mormile, Mortality Moual, Mukherjee Mukherjee, Mulla, Mullan, Mulrow, Multidiscip Munafo, Murad, N N. N., N=100 N=106 N=40 N=56 N=66 N=69 N=80 NHLBI NY, Naik, Nasser, National Nature Naureckas, Nebulized Nerenberg, Network Network, Network. New Nici, No Nordmann, North Not Notably Notably, Note, Number Nunan, Nunes, Nursing Nursing, Nwaru, O'Connell, O'Fallon, O. O., OR Objectives Occupational Of Office Office. Oliver, On Only Ontology Open Oral Organ, Organisation Organisation. Oriss, Other Otolaryngol Outcome Outcomes Overall, Overview Oxygen P. P., PICO PRISMA PRISMA. Pace, Paciocco, Paediatr, Panagioti, Panel Papaioannou, Papiris, Parameswaran, Parameters Park, Parke, Participant Participants Patel, Patients Paton, Peak Pearce, Peden, Pediatrics, Peer Pereira, Perera, Perrin, Persistent Perspectives Pesola, Petrisor, Pharmacological Phillips, Physiol Physiol, Physiological Pinnock Pinnock, Pipher, Pirracchio, Pizzichini, Poetker, Policy Population Postma, Pract, Practice Prednisolone Press. Prevalence Prevention Previous Primary Primers, Prior Prisma Profita, Program Promoting Psychiatry, PubMed/MEDLINE PubMed/MEDLINE, Puri, Q., Qiu, Quality Question Questions R R. R., RCT RCTs RCTs, RCTs. Raatz, Ragan, Ramsahai, Ramsay, Randomised, Randomization Rapid Rationale Ray, Received Recent Recommendations Reddel, Reed, References Reh, Reisman, Relapse Renz, Report Reprod Requiring Res Resche-Rigon, Research Research, Research: Resnik, Resolution Respir Respiratory Results Retrieval Rev Rev, Review Review, Review. Review: Reviews Rhinol, Ribic, Riccobono, Riley, Risk Roberts, Rodrigo Rodrigo, Rodrigues, Rossing, Rousseau, Roussos, Rowe Rowe, S. S., SAGE. Sadatsafavi Sadatsafavi, Sanduzzi, Saunders Scarfone Scarfone, Scells, Schneider, School Schuh Schuh, Schunemann, Sci, Science Search Searches Secondly, Section Selecting Self-Management Self-management Services. Severe Sexually Shanghai Sheikh, Shields, Significant Significantly Silva, Silverstein, Similarly, Simpson, Singhi, Six Skills Sly, Soares, Soc Soc, Social Society, Society. Some Sood, Spector, Spooner, St Stanziola, States Stephens, Stevenson, Stoddart, Stopping Strachan, Strahm, Strategy Strengths Strewart, Studies Study Subjects Suboptimal Successful Such Summary Suresh, Surgery, Sutton, Symptoms Synthesis Synthesis, Syst Systematic Systemic T. T., Table Taylor, Teague, Techniques Tenenbaum, Tennis, Terms Tetzlaff, The Thematic-Style There Therefore, Thirdly, This Thomas, Thorac Thoracic Thorax, Thus, Time To Torgerson, Torjesen, Training, Transmitted Treated Trial Trials, Trials. Truncation-2 Tsafnat, Tuche, Two UK UK, UK-based UK. United University Urrutia, Uruguay V. V., Vale, Vandvik, Variability Vatrella, Vignola Vitale, W. W., Walter, Wang, Wanner, Wark, Was Weaned Weiss, Wenzel, Were Westfal, What When Whilst Whilst, Who, Why Wiley, Workshop World X. Y., York, You, Your Yunginger, Z. Zhang, Zhou, Zuccon, Zuwallack, [accessed [online]. a above above, above. absence absenteeism, abstract abundance accelerate accessory according account accounted accounting accounts acetate achieve achieved achieved, achieved. achieving acknowledging acronyms, across action acute add addition addition, additional address addressed addressed. adds adequate adequately adhere adherence adherence, adjustment administered administered, administration admission admission, admission. admissions admissions, admissions. admitted adopt adopting adoption adult adulthood, adults adults. advances adverse advocate advocated affect affects after again, age age-adjusted aged aggressive aid aim aimed aims aims, airflow airway airways airways, al. al., all allergic allocation allow allowed allows almost alone already also also, alter altering alternative although ambulatory aminophylline among an analyse analysed analyses analysis analysis, and and/or annual annum antibiotics any apparent appears appendices appendices, appendices. applicability applicability, applicability. applicable applied applying appraisal appraisal, approach appropriate appropriate. appropriately approval approval, approximately are arising arose articles as ascertainment aside aspect assessing assessment assessment, assignment assist associated associations asthma asthma, asthma-related asthma. asthma: asthmatic asthmaticus; asthma’, at atopic attained attempt attributable attributed attrition authors availability available avoid avoidable background balanced barrier base base. baseline baseline) baseline), baseline, basic be became been being below below) below). below, below. benefit benefit: benefits benefits. best beta-agonist beta-agonists beta-agonists, better between bias bias, bias. bias: bias? biased billion biological biomedical birth blinding blinding, block blue bodies. body both bowel broad bronchial bronchodilators, bronchospasm. budesonide budesonide, burden but by calculation calculations can cannot capacity capacity, care care, care. case cases, causes cell central challenging. change? characteristics characteristics. characterized children children, children. chosen chronic cigarettes, circumstances classified clearly clinical clinical, clinically clinician co-morbidities cohort collective collectively, combination combined comment common commonest community community-based community. comparable comparator comparator, comparators compared comparison comparison, complacency completed complex complicated comply component comprehended comprehensive comprehensive, comprise comprised computer-generated concealed concealment concept: concern concerns concluding conclusion conclusion? condition condition. conditions conditions, conduct conduct, conducted conducted, conducting confer confidential confidentiality confidently conflicts confound confounded confounders, confounders. confounding congruence congruent consenting consequent consideration considered considered. considered? considering consistency consistently constitute constructing construction contain contained contains contrast, contrasted contributing control control, control. control: controlled controls controls, converted correlating corticosteroid corticosteroid) corticosteroids corticosteroids, corticosteroids. corticosteroids: cortisone cost cost. costs costs, costs? could countries countries, counts: course courses covariable covariables credibility credible criteria criteria, criteria; critical cross-sectional current currently cut-off da daily data data, data: database database, databases databases. day, days days, deaths deaths, deaths. deaths: decades decades, decision decision-making. deemed defined defined, definitions degree delayed delivery demand demonstrated demonstrated. demonstrating department, department: dependent derivation derive derived described descriptive descriptively design design, designed designs despite detail, detailed details detect determinations determinations, determine determined develop developed development development. dexamethasone diabetes diagnosed diagnosis diagram dictated did difference difference. differences differences. different differential differing diligently direct directly disability discharge discharge. discharged discussed discussion discussion, disease disease, disease-related disease. diseases, diseases: dismissed disorder dissertation distress distress, do does domain domain; domains. domestic dose doses double double-blind double-blind, drive drop-outs drug drugs, dual due duplicates, duration durations during dyspneal each earlier early early-onset easily economic edition. education effect effect. effective effectiveness effects effects, effects. efficacy efficacy, efficiency efforts either elaboration. electronic eligibility eligible emergence emergency emphasised encourage end end, endotypes. enough enquiry ensure ensured ensures ensuring enteral entered environmental eosinophilic epidemiological epidemiology epidemiology, epistemological epistemology. equally, equally? equipped equivalent error essential establish estimated estimates estimates. et ethical ethically ethics evaluate evaluated evaluating event events every evidence evidence, evidence-base, evidence. evident evident, exacerbation exacerbation, exacerbation. exacerbations exacerbations, exacerbations. example exceeding excellent excess excluded excluded, exclusion exclusion, exclusions exclusions, expected expensive. experience experience. experiencing experimental expertise expiratory explanation explore exposure extent, external facilitate factor factors factors. failed failure false-negative false-positive faster feasible feasible. few field. fifth figure filtering final finding, findings findings, finds. first five flow flunisolide fluticasone focus focused focuses foetal follow-up follow-up, followed following for forced form formal formally former formulated formulations formulations. forward found four fours fourth framework free frequency from from: full fully function function, functional funding further future gender general generalisability generalisability, generalisable generally generally, generate generated generates generation genetic given global goal, gold good governing grant greater green gross grounding group group, group. groups groups, groups. guide guide. guided guideline guidelines had half harms has have having headings, health healthcare heart help helps herein heterogeneity heterogenous high high-dose higher highest highly home hormonal hospital hospitalisation hospitalizations hospitalized hospitals hours hours) hours), hours, how? however, http://doi.org/10.1016/S0091-6749(99)70228-9 http://doi.org/10.1378/chest.122.4.1208 http://doi.org/10.5694/mja18.00134 http://dx.doi.org/10.1038/nrdp.2015.25 http://err.ersjournals.com/content/errev/24/135/30.full.pdf http://ginasthma.org/2018-gina-report-global-strategy-for-asthma-management-and-prevention/ http://globalasthmareport.org/Global%20Asthma%20Report%202018.pdf http://ukrio.org/wp-content/uploads/UKRIO-Code-of-Practice-for-Research.pdf http://www.bmj.com/content/344/bmj.d7762.abstract http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1116277/ http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2267325/ http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2912019/ http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2947122/ http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3159210/ http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3168054/ http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3847052/ http://www.prisma-statement.org/documents/PRISMA%202009%20flow%20diagram.doc http://www.who.int/respiratory/asthma/en/ https://casp-uk.net/casp-tools-checklists/ https://dl.acm.org/citation.cfm?id=3133080 https://doi.org/10.1002/14651858.CD000195.pub2 https://doi.org/10.1002/14651858.CD001115 https://doi.org/10.1002/alr.21609 https://doi.org/10.1016/S1081-1206(10)60879-4 https://doi.org/10.1016/j.amjmed.2009.02.013 https://doi.org/10.1016/j.jaci.2011.12.983 https://doi.org/10.1016/j.otc.2010.04.003 https://doi.org/10.1056/NEJM198601163140304 https://doi.org/10.1056/NEJM200009073431003 https://doi.org/10.1080/10400419.2014.961781 https://doi.org/10.1098/rsos.160254 https://doi.org/10.1111/j.1365-2222.2011.03929.x https://doi.org/10.1111/j.1651-2227.1999.tb00057.x https://doi.org/10.1152/ajplung.00070.2014 https://doi.org/10.1164/ajrccm/146.4.888 https://doi.org/10.1164/rccm.200410-1415OC https://doi.org/10.1177/0539018412437108 https://doi.org/10.1177/1059840514557235 https://doi.org/10.1183/09031936.00172213 https://doi.org/10.1183/09031936.06.00048605 https://doi.org/10.1183/09031936.06.00137704 https://doi.org/10.1183/20734735.008914 https://doi.org/10.1186/1745-6215-10-49 https://doi.org/10.1186/2046-4053-1-28 https://doi.org/10.1186/s12916-016-0657-8 https://doi.org/10.1186/s12916-017-0823-7 https://doi.org/10.1186/s13643-018-0724-7 https://doi.org/10.1186/s40248-016-0073-0 https://doi.org/10.1186/s40733-016-0029-3 https://doi.org/10.11919/j.issn.1002-0829.215008 https://doi.org/10.1378/chest.13-1619 https://doi.org/10.1513/AnnalsATS.201306-150FR https://doi.org/10.1513/AnnalsATS.201312-448LD https://doi.org/10.1542/peds.2005-2842 https://doi.org/10.1542/peds.2008-1890 https://doi.org/10.4103/0019-5049.190618 https://doi.org/10.4103/0019-5049.190619 https://doi.org/10.4103/0974-1208.82352 https://doi.org/10.4103/1817-1737.140120 https://ebm.bmj.com/content/ebmed/23/1/21.full.pdf https://emj.bmj.com/content/emermed/20/2/164.full.pdf https://pdfs.semanticscholar.org/a6b4/d6d01bd19a67e794db4b70207a45d47d82f3.pdf https://www.asthma.org.uk/globalassets/campaigns/compare-your-care-2014.pdf https://www.asthma.org.uk/globalassets/health-advice/resources/adults/adult-asthma-action-plan.pdf https://www.bmj.com/content/bmj/348/bmj.g3108.full.pdf https://www.brit-thoracic.org.uk/document-library/clinical-information/asthma/btssign-asthma-guideline-quick-reference-guide-2016/ https://www.kingsfund.org.uk/sites/default/files/field/field_publication_file/delivering-better-services-for-people-with-long-term-conditions.pdf https://www.ncbi.nlm.nih.gov/pubmed/10216323 https://www.ncbi.nlm.nih.gov/pubmed/10919507 https://www.ncbi.nlm.nih.gov/pubmed/11940264 https://www.ncbi.nlm.nih.gov/pubmed/13368522/ https://www.ncbi.nlm.nih.gov/pubmed/15072167/ https://www.ncbi.nlm.nih.gov/pubmed/16175830 https://www.ncbi.nlm.nih.gov/pubmed/16816348 https://www.ncbi.nlm.nih.gov/pubmed/19622512/ https://www.ncbi.nlm.nih.gov/pubmed/26528658 https://www.ncbi.nlm.nih.gov/pubmed/3053605/ https://www.ncbi.nlm.nih.gov/pubmed/6340496/ https://www.ncbi.nlm.nih.gov/pubmed/7574132/ https://www.ncbi.nlm.nih.gov/pubmed/7846337/ https://www.ncbi.nlm.nih.gov/pubmed/8958890/ https://www.niehs.nih.gov/research/resources/bioethics/whatis/index.cfm https://www.rcplondon.ac.uk/projects/national-review-asthma-deaths huge human hydrocortisone hydrocortisone, hydrocortisone. hyper-responsiveness, hyperpermeability hypersensitivity hypotheses hypoxaemia, identification identified identified. identified: identified; identify if imbalance imbalances immediate immediate/short immune-mediated immunological impact impact. impaired impairment imperative implications importance important improve improved improvement improvements improving in inadequate inadequate. inadequately inappropriate incidental incidentally include included includes including inclusion inclusion. incomes inconclusive incorporate incorporated incorporation increase increased increases increasing increasingly indeed, independent index index, indicated indicators indices individual individualised individuals induction infer inferior inferred inferring inflammation inflammatory influence influenced inform information informed inhaled inhaled, inhalers inhalers, inherently initial initiated inquiry insignificant instability instances, institutions insufficient intensive intention-to-treat interest, interest. interests intermediate-income intermittency intermittent international interpretation intervals, intervention intervention, interventions interventions, interventions: into intramuscular intravenous intravenously introduce involved ipratropium, irrelevant irritants is issue? issues issues, it iterated its journal, justification. keeping kills: knowledge known laboratory, lack lacking lacking, language large largely last late late-onset later latter lead leading leads learn led left length less lesser level levels life, life-threatening life-years. life: lifestyles likely limitation limitations limited limits linked lists literature literature, little lived local logic logic. logical long long-term longitudinal loss losses low low- lower lowest lung made magnesium, main maintain maintained maintaining major majority make management management, management. managing many marked markedly markers matched maternal maximum may mean meaning meaningful means meant measure measure, measure. measurement: measures measures, measures. median medical medically medication medication, medicine medicines, meet meeting mellitus member memoire mentioned merging met meta-analyses meta-review method methodological methodology methods methods, methods. methylprednisolone methylprednisolone, mild million millions minimise minimised minimised, minimises minor minority minute minutes minutes), minutes, misconduct misconduct, missed missing mixed mixed. moderate modern modestly molecular monitoring montelukast months, moral morbidity morbidity, morbidity. more mortality mortality, mortality. most mostly much multiple muscle narrowing national nations nations: nature nearly nebulisation nebulisation. nebulisations, nebulised nebulized necessitate need needed needs negates next no non-English non-atopic, non-compliance non-genomic non-inferior non-inferiority non-primary non-significant nor normally not notably, note note, noted notes novel number nursing: nutritional obesity-related objective objectives objectives. objectivity observation observational observe observed observing obstruction obstruction, obstruction. obstructive obtained obtaining occupational occurred occurrence of offer official often on one ongoing online only onset ontological opportunity optimal optimised optimising optimization or oral oral, oral/intravenous order organisation original other others otherwise outcome outcome) outcomes outcomes, outcomes. outcomes: over over-estimated over-estimates overall overall, overly-selective overview own oxygen p p<0.001) p<0.001), p<0.001). p<0.01). p=0.005, p=0.008) p=0.01), p=0.017) p=0.04). p=0.14, p=0.16). p=0.33, p=0.34). pack paediatric paradigm parameters parameters. parental parenteral parodoxus, part part, participant participants participants, particular partly past pathophysiology pathophysiology. pathophysiology: patient patient-initiated patients patients, patients’ patterns. peak peer-review peer-review, peer-reviewed people per percent performance permanent person personalised personalized personnel persons persons, perspective, perspective. pertaining pertinent pharmaceutical pharmacological pharmacotherapy phase phenotype, phenotypes phenotypes, phrases physicians. physiological placebo placebo. placed places plan planning planning, plans plans, plans. plans? policy poor poorer population-based populations populations, populations. possible post-exacerbation post-onset potential potentially power powered practice practice, practice. practices practices, pre-defined precedes preceding precise precision predicted predisposes predisposition prednisolone prednisolone, prednisone predominantly premature prepared prescribed prescribing presentations, presented presented. presenting presents pressures prevalence prevalence, prevalent prevent preventable preventable, preventable. prevented preventer preventing previous previously primary principle principles principles. prior problem problem, problem. procedures. proceeding process process, processes, produce produced producing product productivity productivity, progressive project: promoted proper properly propionate proportion proportionate proposal. protected protected. protecting protection protocol prove provide provided provided, providers provides provision provocation, puberty public publication published published, pulmonary pulsus quality quality, quantitative question question, question. question: questions, raise randomisation randomisation. randomised randomised, randomised? randomization randomized range rank rapid rarely rate rate, rates rates, rates. rather rationale reached reader reader, readmission receive received receiving recent recognised recognized recommendation recommendations recommendations, recommended recommending recovered red reduce reduced reduces reducing reduction reductions referred refers refine reflected regard regarding regimes, registry. regression relapse relapse. relapses relapses; relate related relationships relatively relevant reliability reliance reliever remain remained remaining remains remission remission, removal repeat replace report reported reporting reports represent representative require required required. requirement requirements requirements. requiring rescue research research, research. researcher researcher. researchers researcher’s resistance resolution resolution, resolve resolving resource respect respective respectively). respectively. respiratory responses responsible restricted restriction, restrictions result resulted results results, results. retain retrieval retrieve retrieved reverse review review, review. review: reviewed reviewing reviews reviews, risk room routine routinely safety salbutamol, same sample samples saturations saturations, scale, science: scope score screened screening screening. screenshot search search. search: searches searching searching, searching. second second, second; secondary section section, section. sections. see seen select selected selection selective self-administer self-administration self-efficacy self-management self-monitored sequalae sequalae. series serious service services services, setting setting. seven several severe severity shift? short shorter should showed shown side signalling significance. significant significant. significantly similar similarly simple single situations six size size. skills small smoked social societal socioeconomic software sole some sources specialist specific sputum standalone standard standards standard’ start statement statements statistical statistically status status, status. stay stay, step-by-step stepping steroid steroid, steroids steroids, still stimuli strategies strategies, strategy strategy, strategy. stratified strength strengths stringent structure structured structuring studied studies studies, studies. study study, study-specific study. sub-analysis subcommittee subheadings; subject subjects subjects) suboptimal subsections subsequent subset substandard substantial substantially subtypes, such such, sudden sufficient suggest suggested suggesting summarily summarised superior superiority support supported supported, supporting supports survey. sustain sustained symptom symptoms symptoms, synthesis synthesis, synthesising systematic systemic systems, table take target targets techniques techniques: template template. terminations, terms terms, test testing, tests text than that the their them thematic thematic-style themes; then theoretical therapy there therefore therefore, these they third thirds this this, thorough thoroughly those three thresholds thresholds, through throughout thus, time time-consuming times tissue title to tools top topic total totals towards trained translation, transparent treat treated treating treatment treatment, treatment-resistant treatment? treatments, trend trends trial trial. trial? trials trials. true truncated truncation two type ultimately umbrella unavailable unbiased unblinded unclear unclear, under under- under-evaluated under-treatment underpowered understanding undertaken. unexpectedly universal unlikely unmeasured unreliable unscheduled unstable untimely up up-to-date updated upon uptake urgent use use, use. used useful users users, using utilisation utilised utilising utility utilization v. valid? validity value value, values variability variable variables variances varicella varied varied. variety vary varying vascular vasculature vasoconstriction vast versus very via viewed vital volume volume, vomiting was we weaning weeks well well-defined were western what what, wheeze, when when, where whereby whereby, whether which which, whilst who whom, why, widely will window with within words, work workers worldwide, worldwide. worse worsening worth would year, years years, years. young £5 ‘PICO’ ‘blind’ ‘brittle ‘comparator’ ‘gold ‘preventer’ ‘reliever’ “AND”) ↑ ↓ ↓; ⇔ ⇔;

Add To Cart

Medicine dissertation

Asthma is defined by the National Institute of Health as a chronic respiratory disease of the airways, that is characterized by airway inflammation and hyper-responsiveness, which causes variable airflow obstruction and upon provocation, intermittent acute exacerbations, with sudden and progressive increases in dyspneal (Mims, 2019). Notably, asthma has been increasingly recognized as a heterogenous disorder with varying clinical and molecular phenotypes (Ray et al., 2019). The phenotypes